The more numerous the remedies for a disease the less likely that any will prove consistently helpful. Of the many drugs recommended for hyperpiesia (essential hypertension) there is no agreement on the best to employ, and none has gained any outstanding reputation. There seems to be no authoritative statement on the comparative value of these remedies, and individual drugs have been praised without controlled clinical observations. The urge for trying new remedies in hyperpiesia is prompted by the common incidence of a condition which produces bizarre symptoms and determines many complications. Although for this reason treatment is a matter of great concern, it is not likely to be very successful while the cause remains unknown.
enlisted for trial not with any faith in their reputed hypotensive qualities but for the purpose of comparing their effects with those of the active drugs. In this way we added to our controls.
The preparations were tried in 70 patients, 13 of whom were males and 57 females. The ages varied from 38 to 72 years and the average age was 58. Before admission into the series each patient was judged to be a case of hyperpiesia after a routine clinical examination which included urine analysis, tests of renal function, retinoscopy, electrocardiography, and radiocardioscopy. On radiocardioscopy, left ventricular enlargement and distortion of the aorta in the form of an unfolding were sought, and when either change preponderated it was noted. Any patient whose systolic blood pressure was less than 160 mm. Hg or whose diastolic blood pressure was less than 100 mm. was excluded from the series. Again, patients in whom a blood pressure of 160/100 was recorded at the first examination were not admitted unless they showed a rise above this at one of two other observations. Any patient with a systolic pressure of 200 mm. or over was not excluded simply because the diastolic pressure was less than 100 mm. No patient with evidence of nephritis was admitted. Any who failed to co-operate during the course of the investigation was rejected.
Each patient attended the London Hospital at fortnightly intervals, but whenever a drug required parenteral administration or closer observation of its effects he was admitted into hospital. At each attendance a resting period of half an hour or longer was assured before starting observations. Questions were then asked about progress during the trial period, any change in symptoms, the occurrence of untoward or toxic manifestations, and any variation in the patient's activity or habits which might influence the course of progress. The blood pressure was then taken (to the nearest multiple of 5 mm.) under conditions which were constant and standard for each patient. The investigation lasted for eighteen months, and over a thousand blood pressure readings were recorded, representing a similar number of observation periods each of a fortnight's duration. We came to place greater reliance on frequent controlled readings of the blood pressure in a limited number of co-operative patients, and so avoided retaining too many in the series.
The drugs were always given in adequate and usually in optimum doses, and this ensured that each patient was under the full influence of the drug soon after the start of the trial period. Although the daily dosage is instanced under each drug, it is to be understood that this was dispensed as three separate doses during the day. If symptoms of intolerance appeared it was discontinued, but was often given another trial after a suitable lapse of time. Although a single trial period usually permitted an opinion on the efficiency of a drug in reducing the blood pressure value, it was as a rule tried over several consecutive periods in a certain number of patients.
Before a remedy was judged to have established a claim to be of value as a hypotensive agent, it had to satisfy certain standards of efficiency. First, it had to be capable of reducing the blood pressure when this was raised and of maintaining it at the lower value. Secondly, it had to demonstrate this action consistently and in a high proportion of patients, thus proving an effect distinct from the lowered pressure which occurs as a natural periodic variation in a patient with hyperpiesia without treatment. Thirdly, this reduction had to be obtained without any toxic symptoms. It therefore became necessary to know the extent to which the blood pressure fluctuated naturally apart from the influence of any active drug. In a series of 650 school children of the ages of 10 to 17 years Lord Dawson (1925) found among 52 in whom the systolic pressure exceeded 130 mm. that this higher reading only remained consistently high in 17 per cent., while in the remaining 83 per cent. it was inconstant. To gain a knowledge of this natural variation in our patients we made use of frequent test periods when the patient was taking a simple placebo mixture, interspersed among test periods allotted to active drugs. The result of one such observation is charted in Fig. 1 
NITRITES
The effects of sodium nitrite on the blood pressure in healthy subjects and in patients with hyperpiesia were observed by Weiss and Ellis (1933) ; a fall usually occurred within 5 to 15 minutes after 1 to 5 grains had been taken by mouth, and averaged 12 mm. for 30 minutes in the healthy subjects and 35 mm. for two hours in the patients with hypertension.
A transient fall in the blood pressure follows the administration of amyl nitrite. Zeiss and Brams (1930) observed the action of amyl nitrite and glyceryl trinitrate on the blood pressure in 10 patients with hyperpiesia and in 10 healthy subjects. Amyl nitrite produced a fall in each of these cases, and glyceryl trinitrate (1/50 grain by mouth) reduced it temporarily in the healthy subjects but not always in the patients with hyperpiesia. The effects of the two drugs were also noted by Burgess (1931) ; amyl nitrite reduced the blood pressure in both groups, but glyceryl trinitrate, in doses of 1/100 to 1/50 grain by mouth or 1/200 grain subcutaneously, did not produce a constant effect.
In successive papers Stieglitz (1927 Stieglitz ( , 1928 Stieglitz ( , 1930 Stieglitz ( , and 1932 has extolled the value of bismuth subnitrate as a vasodilator and as a hypotensive agent in patients with hyperpiesia. He postulated that the beneficial effect depended on the gradual vasodilatation resulting from the continuous absorption of small quantities of nitrite ions and a reduction of the blood chloride which follows the diuretic action of the nitrate ion. Ayman (1932) tried bismuth subnitrate in daily doses of 30 grains for periods of three to nine months in 15 patients with hyperpiesia; his observations were carefully controlled and he concluded that the drug had not lowered the blood pressure in a single case. Bruen (1932) observed the hypotensive action of bismuth subnitrate in healthy subjects, and in 1934 was able to report on such a trial in a series of patients with hyperpiesia. The observations were carefully controlled, so that periods on lactose tablets and oxalate powders were compared with periods on 30, 60, and 90 grains of bismuth subnitrate daily. He concluded that bismuth subnitrate was without influence on either the blood pressure or the symptoms.
Amyl Nitrite.-We observed the effect on the blood pressure of inhalation of amyl nitrite (5 minims) in 22 patients with hyperpiesia and in 18 healthy subjects. There was a fall in both systolic and diastolic pressure in each of the 40 cases, but the change was more noticeable in the former. In the patients with hyperpiesia the systolic fall varied from 10 to 100 mm., and averaged 45 mm. The average time before the fall took place was one minute and its average duration was three minutes. A compensatory rise of an average of 22 mm. only followed in four instances (Fig. 7) . In the healthy subjects the systolic fall varied from 10 to 60 mm. and averaged 33 mm. The average time before the fall took place was one minute and its average duration was six minutes. A compensatory rise of an average of 36 mm. followed in four instances.
Glyceryl Trinitrate.-We also observed the effects on the blood pressure when this was chewedin tablets containing 1/100, 1150, 1125, and 1/12 grain, in 7 patients with hyperpiesia and in 5 healthy subjects. A fall in both systolic and diastolic pressure occurred in each of the 12 cases. The systolic fall was the more noticeable, and in the hypertensive group varied from 25 to 195 mm. with an average of 55 mm. The average time before the fall took place was 6 minutes and its average duration was 16 minutes. In the healthy subjects the fall varied from 15 to 40 mm. with an average of 26 mm. The average time before the fall took place was 4 minutes and its average duration 16 minutes. A compensatory rise of the blood pressure value was not seen in either group. Inhalation of amyl nitrite and the chewing of glyceryl trinitrate will therefore always cause the systolic blood pressure to fall, both in normals and in patients with hyperpiesia, the extent of the fall being greater in the latter. The fall produced with glyceryl trinitrate appears later than with amyl nitrite, but the effect lasts longer. 
IODINE
Potassium iodide intravenously often causes the blood pressure to fall, but Macht (1914) showed that its hypotensive effect was due to potassium and not the iodine ion. Mosenthal (1933) obtained hypotensive effects from the use of sodium and potassium iodide in daily doses of 3 to 10 grains in cases of hypertension. The use of iodine in hyperpiesia is also mentioned by others (Norris, Bazett, and McMillan, 1927 ; Gager, 1930; Hay, 1931 ; Parkinson, 1936 ; White, 1937) . Livingstone (1935) 
SEDATIVES
Bromide.-We have not found reports of any observations on the effects of bromide on the blood pressure in hyperpiesia, but its use has been mentioned especially in connection with the relief of symptoms (Gager, 1930 ; Hay, 1931 ; Parkinson, 1936 ; White, 1937) .
Potassium bromide was tried in 40 patients with hyperpiesia, and its effect observed in a daily dosage of 30 Macht (1916) stated that it slowed the heart rate and reduced the blood pressure through vasodilatation of the peripheral arteries. The use of opium was mentioned by Norris, Bazett, and McMillan (1927) , and White (1937) mentioned papaverine in the treatment of hyperpiesia, but expressed no opinion as to its value.
We submitted papaverine sulphate to a trial in 16 patients with hyperpiesia, and observed its effect in a daily dosage of 7-grains (0 45 g.) during 24 test periods. A fall occurred during 8, conspicuous in 4 and moderate in 4; there was no change during 13 ; and a moderate rise took place during 3.
Symptomatic improvement was recorded during 6 test periods on papaverine sulphate, but during 18 the symptoms either remained stationary or became aggravated. Toxic effects were not seen.
A comparison of these results with those obtained from placebo treatment is made in Table III . We submitted euphyllin (theophylline-ethylene-diamine) to a trial in 31 patients with hyperpiesia, and observed its effect in a daily dosage of 9 grains (0-6 g.) during 41 test periods. A fall occurred during 11 test periods, conspicuous in 4 and moderate in 7 ; there was no change during 23 ; and a rise took place during 7, conspicuous in 2 and moderate in 5.
Symptomatic improvement was recorded during 10 test periods on euphyllin, but during 31 the symptoms either remained stationary or became aggravated. Toxic effects, namely weakness, insomnia, headache, and palpitation occurred twice.
We submitted diuretin (theobromine-sodio-salicylate) to a trial in 26 patients with hyperpiesia, and observed its effect in a daily dosage of either 30 grains (1 8 g.) or 45 grains (2-7 g.) during 30 test periods. A fall occurred during 5 test periods, conspicuous in 1 and moderate in 4 ; there was no change during 16; and a rise took place during 4 test periods, conspicuous in 1 and moderate in 3. In 5 instances the effects could not be recorded because the patients failed to continue taking the drug on account of giddiness, headache and sickness. These symptoms were also present in three others and were more noticeable with the larger dose.
Symptomatic improvement was recorded during 4 test periods on diuretin, but during 26 the symptoms either remained stationary or became aggravated.
A comparison of the results of these drugs and theominal with those obtained from placebo treatment is made in Table IV. Symptomatic improvement was recorded during 7 test periods on theominal, but during 14 the symptoms either remained stationary or became aggravated. Toxic effects, namely giddiness or drowsiness, occurred four times, and compelled the patients to discontinue its use. CHOLINE DERIVATIVES Acetylcholine.-A fall in blood pressure as a result of vasodilatation was shown in the cat by Dale (1914) after small doses of this intravenously. Wolff (1929) was also able to show vasodilatation in organs supplied by the parasympathetic nervous system and a generalized dilatation of the cutaneous arterioles. Meakins and Scriven (1931) recorded a fall of from 25 to 40 mm. in 72 per cent. of their observations on seven cases of hypertension following intramuscular injections of 0 1 to 0-2 g. of acetylcholine; the effect lasted from one to four hours. Only three out of thirteen healthy subjects showed an appreciable fall in blood pressure after intravascular administration of 2 per cent. acetylcholine given at the rate of 0-02 to 0 14 g. per minute (Ellis and Weiss, 1932) . Carmichael and Fraser (1933) gave it intravenously in doses of from 0-01 to 0-03 g. to 46 subjects, and cardio-inhibitory effects appeared within five to ten seconds,but lasted only a few seconds. The slowing of the heart rate was followed by an acceleration, and the systolic and diastolic pressure fell during the phase of slow heart rate, but returned to normal or even higher during the phase of increased heart rate. More recently Fraser (1938) stated that the administration of acetylcholine in man gave disappointing therapeutic results ; when given intravascularly the effects are too brief, and when given intramuscularly too uncertain. Doryl (carbaminoyl-choline) and Mecholin (acetyl-p-methyl-choline) are more stable than acetylcholine and are active even when given by mouth. Their hypotensive properties have been demonstrated by Kreitmair (1932) , Dautrebande (1933) and Fraser (1938) , but Fraser has pointed out that both preparations are valueless in the treatment of hyperpiesia, except for the relief of hypertensive headache. Pacyl is another choline derivative which is said to be active when given by mouth. Lewy (1928) and Ganter (1928) reported hypotensive effects and symptomatic improvement from its use. The preparation hypotan is a mixture of methylacetylcholine, bromocholine bromide and chloral hydrate. Its use in hypertension has been recommended on account of its alleged action as a vasodilator.
We submitted doryl to a controlled clinical trial in 11 patients with hyperpiesia, and observed its effect in a daily dosage of 6 Altnow and O'Hare (1927) used calcium chloride and atropine in the treatment of 11 cases with hypertension ; no fall in pressure was noticed in 6 and it was insignificant in the remaining 5 patients.
Calcium chloride was tried in 20 patients with hyperpiesia, and its effect observed in a daily dosage of 90 grains (6 g.) during 25 test periods. A fall occurred during 4, conspicuous in 1 and moderate in 3 ; there was no change during 11 ; and a rise took place during 6, conspicuous in 2 and moderate in 4. In 4 other instances it was not possible to record the effects because of a burning taste in the mouth, sickness or epigastric pain.
Symptomatic improvement was recorded during 6 test periods on calcium chloride, but during 19 the symptoms either remained stationary or became aggravated.
Atropine.-This has been recommended for hypertension on the assumption that raised blood pressure is the outcome of an unbalanced action in the autonomic system, so that the vagal action preponderates over the sympathetic. Altnow and O'Hare (1927) treated 11 patients with calcium chloride and atropine, but without any change in 6 and with an insignificant change in the remaining 5. Norris, Bazett, and McMillan (1927) stated that experimentally atropine raises the blood pressure through stimulation of the vasoconstrictor centre and raising the pulse rate, but that this pressor effect was rarely met with clinically. White (1937) also mentioned the use of atropine in hypertension.
We submitted atropine sulphate to a trial in 9 patients with hyperpiesia, and observed its effect in a daily oral dosage of 1/20 grain (0 003 g.) during 9 test periods. A moderate fall occurred during 1 test period ; there was no change during 5 ; and a rise took place during 2, conspicuous in 1 and moderate in another. In one instance it was not possible to record the effects because of dryness of the mouth and mistiness of vision, and these symptoms were also present in 6 others who persisted with the drug.
Symptomatic improvement was recorded during 3 test periods on atropine sulphate, but during 6 the symptoms either remained stationary or became aggravated.
Potassium Thiocyanate (potassium rhodanate).-During a clinical trial of the effects of cyanate in patients suffering from neurasthenia, Pauli (1903 and 1904) observed both a reduction in the pressure and an improvement of symptoms when hypertension was present. Nichols (1925) stated that the drug was excreted slowly and that cumulative effects might appear ; it was, however, excreted unchanged without the formation of the poisonous prussic acid radicle.
Therapeutically he found it reduced the blood pressure to a greater extent than any other drug in hyperpiesia. Smith and Rudolf (1928) gave sodium sulphocyanate to five healthy subjects and to 72 cases with hypertension, the daily dose for one group being 5 grains, for another 10 grains and for a third 15 grains A fall in blood pressure occurred in each of the healthy subjects and each of the patients with hypertension, and the change was more noticeable in the latter. They observed a fall of as much as 100 mm. in the systolic pressure, and as a rule the greater fall followed the greater dosage. Better results were obtained in those patients without evidence of renal damage and in those who showed the least amount of arterial changes from atheroma. No severe toxic symptoms were noticed. Gager (1928) (Bolotin, 1932 ). Both Palmer (1932 and Goldring and Chassis (1932) found that thiocyanate reduced the pressure in 31 per cent. of cases ; but Palmer found it did not persist and that often where it had fallen initially with treatment a retrial failed to reproduce this effect. Goldring and Chassis found toxic symptoms in 17 per cent. of their cases, and two deaths were attributed to the drug. A fall in the pressure was noted by Ayman (1931) in 20 of 31 cases with hyperpiesia, but in 19 out of the 20 it was accompanied by distressing toxic symptoms, both in large doses over short periods and in small doses over longer periods. Barker (1936 and stressed the importance of estimating the cyanate content of the blood during treatment, and thought the optimum benefit occurred when it was maintained at 8 to 12 mg. per 100 c.c.; when it reached 15 to 30 mg. toxic symptoms appeared. The standard concentration in the blood was never obtained by a constant cyanate dosage. He stated that if the concentration was maintained at a suitable level, a fall in blood pressure and symptomatic improvement would be expected in 50 per cent. of cases. When this standard concentration was maintained in 16 patients with hypertension, Griffith and Lindauer (1937) found that both the systolic and diastolic blood pressure became lowered in 10 with improvement of general symptoms and without any severe toxic effects. Massie, Ethridge, and O'Hare (1938) gave sodium thiocyanate to 14 patients with hyperpiesia, under controlled conditions, and found it reduced the pressure and improved the symptoms.
We submitted potassium thiocyanate to a trial in 38 patients with hyperpiesia, and observed its effect in a daily dosage of 41 grains (0-3 g.) during 90 test periods.
A fall occurred during 34, conspicuous in 11 and moderate in 23 ; there was no change during 36 ; and a rise took place during 20, conspicuous in 6 and moderate in 14. Symptomatic improvement was recorded during 31 test periods on potassium thiocyanate, but during 59 the symptoms either remained stationary or became aggravated. Toxic effects were not seen.
Benzyl Benzoate. -Macht (1918) , as the result of experiments in animals, found this diminished the tonicity of smooth muscle, and decided on a clinical trial in intestinal colic, bronchial spasm and angiospasm. Using 45 minims of a 20 per cent. alcoholic solution daily he claimed good results in 100 cases, including many with hyperpiesia. Later Macht (1920) reaffirmed his opinion on its beneficial effects and gave further examples in which a raised blood pressure had been reduced by the daily administration of from 60 to 90 minims of the 20 per cent. alcoholic solution. These observations were not con-trolled and the proportion responding successfully was not expressed. Laubry and Mougeot (1921) submitted benzyl benzoate to a clinical trial and concluded that it was a useful drug to combine with others because it gave results which were sometimes surprising, rarely negligible, and never harmful. Gruber and Shackelford (1924) gave 120 minims of the 20 per cent. alcoholic solution of benzyl benzoate daily for periods of four to eighteen days to 16 patients with hyperpiesia. Their observations were carefully controlled and appeared to show that when given by mouth it had no effect on the raised pressure in hyperpiesia.
We submitted benzyl benzoate to a trial in 30 patients with hyperpiesia, and observed its effect in a daily dosage of 24 minims (1 6 
SOME VEGETABLE EXTRACTS
Guipsine.-This is a preparation of mistletoe which has been advocated on account of its alleged action as a vasodilator of the peripheral arterioles.
Guipsine was tried in 12 patients with hyperpiesia, and its effect observed in a daily dosage of 9 pills during 19 test periods. A fall occurred during 6, conspicuous in 1 and moderate in 5 ; there was no change during 9 ; and a rise took place during 4, conspicuous once and moderate in 3 instances.
Symptomatic improvement was recorded during 4 test periods on guipsine, but during 15 the symptoms either remained stationary or became worse.
Detensyl.-This consists of extracts of mistletoe, liver, pancreas and lung and because a hypotensive action from vasodilatation has been ascribed to each of these constituents it has sometimes been recommended.
We submitted detensyl to a trial in 14 patients with hyperpiesia, and observed its effect in a daily dosage of 4 tablets during 18 test periods. A fall occurred during 4 test periods, conspicuous in 1 and moderate in 3 ; there was no change during 9; and a rise took place during 4, conspicuous in 1 and moderate in 3. One patient failed to take the tablets.
Symptomatic improvement was recorded during 6 test periods on detensyl, but during 12 the symptoms either remained stationary or became aggravated.
Phyllosan is the name given to a concentrated extract of chlorophyll obtained from green vegetables. Originally recommended in the treatment of anemia, it has recently been accredited with hypotensive effects, but on such meagre evidence that we accepted it into our series for additional control observations.
We submitted phyllosan to a trial in 9 patients with hyperpiesia, and observed its effect in a daily dosage of 6 tablets during 16 test periods. A moderate fall occurred during 4 ; there was no change during 9 ; and a rise took place during 2 test periods, conspicuous in one and moderate in another. The effect could not be recorded in one patient because he was unable to take this medicine on account of giddiness.
Symptomatic improvement was recorded during 5 test periods, but during lIthe symptoms either remained stationary or became worse.
Citrin (cucurbocitrin).- Barksdale (1926) isolated an active principle from the seed of the water-melon which belongs to the group of glucoside-saponins and which prove on experiment to dilate the smaller arteries. Barksdale claimed good results in 10 cases of nephritic hypertension. In 68 patients in whom the blood pressure was raised, Wilkinson (1927) found a fall with symptomatic improvement in 82 per cent. Cucurbocitrin was given by Althausen and Kerr (1929) in daily doses of 150 to 450 mg. to 40 patients with hypertension. An immediate fall in pressure was noticed and its extent appeared to be directly dependent on the dosage. After prolonged administration an average fall of 29 mm. in the systolic and of 15 mm. in the diastolic pressure occurred in 73 per cent. of the cases, while symptomatic improvement was recorded in even more ; toxic symptoms were never noted. Gargill and Rudy (1931) treated 29 cases of hyperpiesia with cucurbocitrin and found it of no value; in only 7 instances was the systolic pressure reduced by 25 mm., a reduction which might occur spontaneously. Seward (1931) prescribed it in 16 patients in doses varying from 150 to 200 mg. daily. The blood pressure was reduced in 4 after treatment for fourteen days, and this effect lasted for some time and went with symptomatic improvement. Later he (1932) reported that in 9 out of 22 cases the systolic pressure was reduced by 30 mm. and the diastolic by 10 mm. following treatment with citrin in doses of from 300 to 400 mg. daily.
We submitted citrin to a trial in 13 patients with hyperpiesia, and observed its effect in a daily dosage of 300 mg. during 13 test periods. A fall occurred during 2 test periods, conspicuous in 1 and moderate in 1 ; there was no change during 7 ; and a rise took place during 2, conspicuous in 1 and moderate in 1. In 2 instances the patients were unable to continue taking the medicine.
Symptomatic improvement was recorded during 4 test periods on citrin, but during 9 the symptoms either remained stationary or became aggravated.
Toxic effects, namely headache, insomnia and a sense of choking, occurred in 3 instances.
Yohimbine, an alkaloid obtained from yohimbine bark, is a peripheral vasodilator, and produces a small hypotensive effect. It is said to augment the action of other agents, and Loeper and Lemaire (1930) found that in dogs previously treated with yohimbine, the hypotensive effects of acetylcholine were four times as great. Barrieu (1932) reported good results from such a combination when given to patients. Taken with phenylethyl-barbituric acid it was favoured by Busquet and Vischniac (1935) .
We submitted yohimbine hydrochloride to a trial in 16 patients with hyperpiesia, and observed its effect in a daily dosage of 1/3 grain (0-02 Vagotonine is obtained from the pancreas, and its specific physiological action is said to be one antagonizing the action of adrenaline and restraining its secretion ; through its action on the sympathetic system it reduces vasomotor tonicity. Abrami, Santenoise, and Bernal (1933) recorded a fall in the blood pressure in 42 of 80 cases of hypertension after subcutaneous injections of 20 or more often 40 mg. of vagotonine. If a fall did not occur within two hours of the first injection, they did not expect any reduction from daily injections even when repeated on twenty consecutive days ; on the other hand, the fall which commenced within two hours was maintained from 12 to 48 hours. Urticaria was sometimes seen.
We observed the effects of a subcutaneous injection of 0-02 g. of vagotonine in 6 patients with hyperpiesia, and in one of these the injection was repeated. Frequent blood pressure readings were taken before and after the injection for a period not less than two hours, and further readings were recorded on subsequent days. We also had evidence of the variation in the blood pressure value during periods of treatment with active drugs or placebo mixtures. In none of our 6 patients was the blood pressure lowered, either immediately or more remotely, by injections of vagotonine and indeed it was at a higher level after the injection in 4 of them. We concluded that vagotonine had no place in the treatment of hyperpiesia, for in the patients in whom it was given a trial it produced no hypotensive effects. In one patient it gave rise to very severe urticaria.
Angioxyl is an insulin-free extract of pancreas which is standardized physiologically. It has been claimed that it antagonizes the action of adrenaline and that it produces vasodilatation, resulting in a lowering of the blood pressure.
We submitted it to a trial in 10 patients with hyperpiesia, and observed its effect in a daily dosage of 80 units during 15 test periods. A fall occurred during 5, conspicuous in 3 and moderate in 2; there was no change during 5 ; and a rise took place during 4, conspicuous in 2 and moderate in 2. In one instance the patient had failed to take the medicine on account of headache.
Symptomatic improvement was recorded during 5 test periods on angioxyl, but during 10 the symptoms either remained stationary or became aggravated.
Bioglan H consists of a concentration of hormones obtained from pancreas, anterior pituitary and human placenta. In 20 cases of hypertension selected from the druggist's laboratory files it is recorded that an average blood pressure of 210/117 before treatment became 158/91 after treatment, and this reduced value had persisted for a year after the initial course of injections.
One c.c. of bioglan H was injected intramuscularly twice weekly for three weeks in four female patients with hyperpiesia, and for two weeks in a male patient. Daily blood pressure readings were taken under controlled conditions and when these were considered it was found that in no instance had it caused any reduction.
A comparison of the results of these preparations and of anabolin with those obtained from placebo treatment is made in Table VII . 15 (20) 33 (45) 41 (35) 26 (20) 34 (25) 66 (75) Anabolin ..
35 (52) 18 (24) 61 (61) 21 (15) 20 (27) 80 (73) Figures, excepting those in the first column, denote percentage of test periods. Figures in brackets apply to placebo.
Anabolin is an extract of liver isolated by alcohol fractionation methods, and its introduction into clinical medicine in the treatment of hyperpiesia has depended on its specific action as a vasodilator. Its pharmacological action in lowering blood pressure in the experimental animal is constant and uniform, so that solutions containing it can be standardized by this method. Major (1924 and 1925) appeared to show that hypertension could be induced experimentally by the introduction of guanidine bases, and because he was able to reduce this rise by the administration of liver extract he postulated that its hypotensive action did not depend solely on vasodilatation, but that it also assisted the liver in destroying pressor bodies in the form of amino-acid waste products. Later (1926) in 100 patients with hypertension he reported that an immediate fall in the blood pressure could be obtained from liver extract injections, and that this effect was often conspicuous and lasted for several hours. MacDonald (1925) those obtained from the use of a placebo only (Fig. 1) , we concluded that dietetic treatment which effected a considerable reduction in the body weight did not influence the blood pressure in patients with hyperpiesia, although symptomatic improvement from loss of weight usually took place. During the period when the weight was falling quickly and later when the reduced weight was being maintained the blood pressure showed a variation which we have come to regard as a normal occurrence in a patient with hyperpiesia ( Fig. 1) . Observations in these five obese patients undergoing dietetic treatment have in this way provided us with another opportunity of watching this natural variation.
DISCUSSION OF RESULTS Natural Variation in Blood Pressure Although we knew that the blood pressure fluctuates from time to time, becoming higher during periods of nervousness, as this investigation proceeded we came to realize more fully how great is the natural variation and how false would be the judgment of the hypotensive action of a drug if this were ignored. No drug should be credited with such properties unless it has exerted this effect to a greater extent than that which occurs naturally during a period on placebo treatment. Fig. 1 shows these periodic changes in the blood pressure during a time when a placebo medicine was the only form of treatment. Similar variations are seen in Figs. 2 to 6 in patients on a reducing diet and a placebo.
Again, the initial blood pressure, i.e. the first reading, is often so much higher than the standard for the individual patient that a disregard of this fact has led to a wrong estimate of the hypotensive properties of certain drugs. Thus among those patients in whom a second reading differed from the first by more than 25 mm. while on placebo treatment there was a fall in three-quarters of the cases. Frequently the systolic value fell 40 mm. and often more than 60 mm. (see Table VIII ). We attributed the higher initial readings to the 
Effect of Drugs on the Blood Pressure
Not until our records were completed did we examine the results critically, and then it was apparent that although these patients had been taking continuously the many reputed remedies none showed any clinical change nor any effective fall in blood pressure. It never assumed a value during treatment with any of the 33 remedies tried that was lower than the value recorded in the same patient when an inert placebo was exhibited. It is remarkable that even when considered statistically (see Table XI An estimate was made of the symptomatic improvement gained by patients under treatment with the various remedies. The improvement was always assessed by a comparison with progress shown during test periods on a placebo. Improvement greater than that shown during placebo treatment was only found in six of the active drugs, bismuth subnitrate, iodine and iodide, bromide, sodium luminal, theominal and potassium thiocyanate. Excepting bismuth subnitrate, they only proved slightly superior to a placebo. In patients manifesting nervousness, restlessness and sleeplessness, bromide, sodium luminal and theominal often ameliorated the symptoms, but without any associated effect on the blood pressure.
SUMMARY AND CONCLUSIONS
The effect of 33 preparations on the blood pressure and symptoms was watched in 70 patients with hyperpiesia (essential hypertension) over a period of eighteen months. The drugs or preparations were various and included nitrites, iodides, sedatives, xanthine and choline derivatives, vegetable extracts and hormones. Naturally it was not possible to test each remedy in every patient as some were accepted after the investigation had begun and a few failed to complete the whole course. Each medicine was prescribed in optimum doses for test periods of a fortnight, and at the end of each period the patient attended for re-examination, when the blood pressure was recorded under the same unvarying and standard conditions and any change in symptoms was noted.
When the basic pressure for each patient had been estimated from the first three observations, the hypotensive effect (or absence of effect) of a particular drug was often decided in individual patients at the end of a test period of 14 days, but as a rule each drug was given a second trial over longer intervals in a certain number of patients. To begin with, and later at irregular intervals, control test periods were instituted for each patient, when an inert placebo mixture was the only treatment given. In two patients the blood pressure was recorded throughout the investigation while taking a placebo of which the colour and flavour were the only variants. In five obese patients it was recorded while on a reducing diet and without drugs.
After allowance had been made for the tendency to obtain high blood pressure readings at the first and possibly at the second examination, and for the natural variation, and when the results from the tested drugs were compared with those from a placebo, we found that none of the 33 preparations produced hypotensive effects in patients with hyperpiesia. In regard to symptomatic improvement, only 6 of the drugs, namely bismuth subnitrate, iodine and iodide, bromide, sodium luminal, theominal and potassium thiocyanate, on an average relieved symptoms rather more than did the placebo. The sedative drugs seem to have value in temporarily relieving nervous symptoms when these were prominent.
Although these results may surprise some, they will accord with the expectation and experience of many physicians. Admittedly, this paper deals with only a small section of the therapeutics of hyperpiesia, and it does not bear on the management of hypertensive heart disease including heart failure, where drug treatment can often be seen at its best. Our negative findings with drugs in uncomplicated hyperpiesia do not make it less desirable that the patient should remain under medical supervision. It is obvious that a patient should not regard his symptoms as closely related to the height of his blood pressure. Medical attention must be devoted to the alleviation of symptoms when they arise and to correcting faults in living, and particularly to the adoption of timely active measures when symptoms or signs of heart failure first appear.
Time will show whether surgical measures are a practicable means of lowering blood pressure and of lessening symptoms in hyperpiesia. Meantime a clearer insight into the origin of hypertension must precede its successful treatment with drugs.
